›› 2020, Vol. 11 ›› Issue (4): 227-231.

• 论著 • 上一篇    下一篇

ROS/HIF-1信号通路调控口腔鳞状细胞癌肿瘤浸润T淋巴细胞分化的机制

谢文强1,卢涣滋2,林冬佳1,杨利洒1,王智3   

  1. 1. 中山大学附属口腔医院?中山大学光华口腔医学院 广东省口腔医学重点实验室
    2. 中山大学附属口腔医院?中山大学光华口腔医学院 广东省口腔医学重点实验室 广州
    3. 中山大学附属光华口腔医院
  • 收稿日期:2020-07-19 修回日期:2020-11-10 出版日期:2020-12-25 发布日期:2020-12-31
  • 通讯作者: 王智 E-mail:wangzh75@mail.sysu.edu.cn
  • 基金资助:
    国家自然科学基金;广州市民生科技产学研协同创新重大研究专项

The ROS/HIF-1 signaling pathway regulates the differentiation of T lymphocytes in OSCC

  • Received:2020-07-19 Revised:2020-11-10 Online:2020-12-25 Published:2020-12-31

摘要: 目的:探究口腔鳞状细胞癌(OSCC)肿瘤微环境中活性氧(ROS)对肿瘤浸润T淋巴细胞分化的作用。方法:流式细胞术分析OSCC肿瘤组织和远端正常组织T淋巴细胞各分化亚群比例,ROS试剂盒检测T淋巴细胞各分化亚群ROS表达情况,实时荧光定量PCR检测癌及远端正常组织中低氧诱导因子1A基因(HIF1A)、葡萄糖转运蛋白1基因(GLUT1)、己糖激酶2基因(HK2)等T淋巴细胞代谢相关基因,利用GEPIA2数据库分析T细胞HIF1A在肿瘤及远端正常组织的差异表达及其与预后的相关性。结果:与正常组织相比,效应T淋巴细胞(CD45RA+ CCR7?)在癌组织中所占比例较高(P<0.05);癌组织中CD3+ T淋巴细胞的ROS含量高于正常组织(P<0.05),癌组织中效应T淋巴细胞的ROS含量高于效应记忆性T淋巴细胞(P<0.05),正常组织中效应T淋巴细胞和效应记忆性T淋巴细胞中ROS含量未见统计学差异(P>0.05);癌组织中T淋巴细胞HIF1A、GLUT1、HK2表达高于正常组织T淋巴细胞(P<0.05);T细胞HIF1A水平在肿瘤组织中比较高,但未见统计学差异(P>0.05),肿瘤组织中效应T细胞的HIF1A水平明显高于远端正常组织,差异具有统计学意义(P<0.05);T细胞高表达HIF1A的肿瘤相对预后较好(P<0.05)。结论:OSCC肿瘤微环境中ROS/HIF-1信号通路上调与肿瘤组织中高比例的效应T淋巴细胞存在高度相关性。

关键词: 口腔鳞状细胞癌, T淋巴细胞, 糖酵解, 活性氧, 低氧诱导因子-1

Abstract: Objective:To explore the effect of reactive oxygen species (ROS) on the differentiation of tumor infiltrating T lymphocytes in oral squamous cell carcinoma (OSCC). Methods: The proportion of T lymphocyte subsets in tumor and distal normal tissue were analyzed by flow cytometry. ROS expression was analyzed with ROS kit. Genes associated with T cell metabolism (HIF1A, GLUT1, HK2) in carcinoma and distal normal tissues were quantified by real time qPCR. GEPIA2 database was used to analyze the differential expression of T cell HIF1A in tumor and distal normal tissues and the prognosis value of mRNA level of T cell HIF1A in patients. Results: The proportion of effectors T cells (CD45RA+ CCR7?) in cancer tissues was significantly higher than that in distal normal tissues (P<0.05). The abundance of ROS in CD3+ T cells in cancer tissues was higher than that in distal normal tissues (P<0.05), and in cancer tissues, the ROS was significantly accumulated in effector T cells up-regulated compared with its counterpart in effector memory T cells (P<0.05). There were no statistically significant differences of ROS between the effector T cell and effector memory T cell in the distal normal tissue (P>0.05). Expressions of HIF1A, GLUT1, HK2 in tumor-infiltrating T cells were higher in those in distal normal tissues (P<0.05). T cell HIF1A level was higher in tumor tissues than that in distal normal tissues, but no significant statistical difference was found. The HIF1A level of effector T cells in tumor tissues was significantly higher than that in distal normal tissues (P<0.05). Patients with higher expression of HIF1A in T cell have a better prognosis (P<0.05). Conclusions:The upregulation of ROS/HIF-1 signaling pathway in the OSCC tumor microenvironment was significantly correlated with the high proportion of effector T lymphocytes in tumor tissues.

Key words: oral squamous cell carcinoma, T lymphocyte, glycolysis, reactive oxygen species, HIF - 1